BIO Introduction
BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Our mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).
The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.
The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.
BIO Protocol
BIO protocol is a new financial layer for decentralized science aimed at accelerating the flow of capital and talent into onchain science.
The protocol is designed to catalyze an onchain economy of scientific communities (bioDAOs) and create deep, liquid, efficient markets for scientific IP developed by bioDAOs.

Protocol Goals
Curation, creation and acceleration of new bioDAOs funding science onchain.Perpetual funding and liquidity for bioDAOs and onchain biotech assets.Standardization of bioDAO frameworks, tokenomics and data/product suites.Generation and commercialization of scientific IP and data.
Core Operations
To achieve these goals, the BIO protocol has 5 core operations:
CurationFundingLiquidityBio/acc RewardsMeta-Governance
1. Curation (BIO Staking)
BIO token holders participate in curating which new BioDAOs join the ecosystem, enabling a bottom-up approach to funding science. The BioDAOs that are selected by the community are then funded, added to the treasury and ultimately supported by the BIO protocol. As the BIO Protocol relies on high quality BioDAOs, curation requires locked BIO to participate, ensuring that those participating are long-term aligned with the network.Using vBIO (locked BIO), BIO holders will have the ability to pledge their conviction in a new DAO applicant that is presented to the BIO Protocol by “Operators” (network stakeholders who support the incubation phase of a BioDAO).BIO holders use vBIO tokens to pledge which BioDAOs they want accepted, and if a DAO they’ve pledged on is voted in, the stakers get access to whitelisted funding rounds, and privileged access to the DAO’s products, data or services.
2. Funding
If the BioDAO applicant is accepted into the BIO Network, all vBIO stakers who pledged to that BioDAO will have the ability to participate in the initial private auction - a whitelisted pre-seed round.Through BIO, users are thus able to support groundbreaking science from day one, on equal to or better terms than VCs or other institutions. For BioDAOs, this creates an opportunity to align a pre-established high-value scientific community to become network participants for that specific field of research.
3. Liquidity
BioDAOs should focus on science, not managing liquidity. BIO alleviates this issue by managing bioDAO secondary market liquidity positions.The BIO protocol can support onchain liquidity for the BIO network using the BIO token and other token holdings in the BIO treasury.The BIO token can be paired in liquidity pools with BioDAO tokens (e.g., VITA/BIO, HAIR/BIO), as well as with other assets (e.g., BIO/ETH) to facilitate low-cost conversions in the network, accruing fees and building protocol-owned liquidity (POL).
4. Bio/acc Rewards
‍The BIO protocol can issue rewards in the form of BIO tokens (“bio/acc rewards”) that incentivize bioDAOs to reach key milestones designed to increase network value (AUM).BIO holders might choose to use bio/acc rewards to incentivize bioDAO milestones like funding a certain value of onchain science, maintaining a certain level of token liquidity, developing IP that reaches clinical trials, or generating sales from consumer products/services.
5. Meta-Governance
The BIO protocol will hold various BioDAO tokens in its treasury and can therefore serve as a meta-governance layer empowering BIO holders to govern a wide range of BioDAOs and scientific IP assets.

BIO Value Accrual
The BIO treasury accrues value through a variety of mechanisms, including:
Token Allocations
BIO Network provides incubated BioDAOs with a $100,000 grant in exchange for 6.9% of the BioDAO’s token supply. These token allocation accrue in the BIO Treasury, growing protocol AUM as the network underlying DAOs rise in the value. The BIO treasury can also receive allocations of bioDAO scientific IP assets.
Protocol-Owned Liquidity (POL)
The BIO treasury accrues fees and yields from its onchain liquidity in BIO tokens, BioDAO tokens, IP tokens, ETH, and other assets, building POL.
BIO Token
The BIO token can be used for the following purposes:
Curate BioDAOs to join the BIO protocol programsPriority access to BioDAO token sales and IP-token salesDiscounts on BioDAO health products/servicesMeta-governance in BioDAOsVote on BIO emissions, treasury allocation, and protocol updates
BioDAO
BioDAOs are community-owned scientific research networks. They typically focus on a specific scientific or medical area, and use the power of a globally distributed collective of stakeholders (e.g., patients, scientists and biotech builders) to accelerate the R&D process and develop new IP. BioDAO members pool together resources (data, capital, labor) for the mission of the DAO. By sharing resources, these communities can reduce the cost of innovation and time to commercialization.
BioDAOs raise funding via token sales, and use their treasuries to back and develop biotech projects related to their mission, creating shared IP ownership between their members. BioDAOs use Molecule's onchain IP framework to own, license, and transact in intellectual property generated from the projects they support. BioDAO proceeds from IP and product sales can flow back into the bioDAO's treasuries to fund and translate the next generation of R&D, further advancing the bioDAO’s mission.

BioDAOs have several advantages over traditional scientific models:
Capital Efficiency: Pooled resources lower innovation costsFlexible Work Model: Enable part-time expert contributionsShared IP Ownership: Incentivize contributions through IP ownershipOpen Access: Remove gatekeeping in scientific funding and decision-makingDiversified Portfolio: Bundle many biotech projects simultaneously, reducing risk.
Success Stories:
VitaDAO: Funded $5M+ in longevity science, backed by Pfizer Ventures, partnered with Newcastle University.HairDAO: Targeting hair loss; DAO-owned patent and consumer product, Follicool.CerebrumDAO: Advancing brain health, raised over $1.5M, struck a deal with Fission Pharma to tackle mitochondrial dysfunction in neurodegenerative disease.ValleyDAO: Focusing on synthetic biology, raised $2M+ and partnered with Imperial College London.AthenaDAO: Advancing women’s health R&D, funded $500k in translational research, with 14 IP deals pending.CryoDAO: Advancing the field of cryogenics, raised over $3M for the field, established projects with Oxford Cryotechnology & Advanced Neural Biosciences.PsyDAO: Focusing on psychedelic medicines, having launched OPSY, a new platform leveraging psychedelics trials and data.
Early acceptances in BIO Cohort 2:
Long COVID Labs: Accelerating a cure for 100M+ Long COVID patients. Founded by Rohan Dixit, ex-Stanford Neuroscientist, healthcare entrepreneur and Long COVID survivor.Quantum Biology DAO: Building quantum microscopes to advance bio research. Founded by Clarice D. Aiello, MIT PhD and world-leading Quantum Biology Scientist, and Geoff Anders, Executive Director of Leverage Research.Curetopia (Rare Diseases): Tackling the $1T+ rare disease space by uniting families and patient communities. Founded by Ethan Perlstein, Harvard PhD, entrepreneur & Y-Combinator alumnus.
Curation
BIO token holders curate which bioDAOs are accepted into the BIO network by staking BIO tokens on bioDAOs they want accepted.
BioDAOs voted into the network receive funding via the BIO Launchpad, as well as token liquidity support, incentives and other acceleration services from the community.
If a DAO you've staked to is ultimately voted in by the community, you stand to earn BIO token rewards as well as early access to the DAO's initial token funding round and IP asset funding rounds conducted by the DAO.

Bio/Acc Rewards
Bio/Acc Rewards incentivize bioDAOs and their members to take actions that contribute to the network's overall value. Per BIOPSY-5, 4% of the BIO token supply (132.8M tokens) will be allocated to Bio/Acc Rewards.
Bio/Acc Rewards provide rewards in the form of BIO tokens to bioDAOs for achieving key milestones, including:
Initial token auctions via the BIO LaunchpadFunding science (IP-Token launches)Consumer product launches with significant revenueConducting decentralized clinical trials
Rewards can also flow directly to users of bioDAO products, incentivizing biohackers to perform activities like:
Contributing to clinical trials or self-reporting health dataUsing bioDAO products (Follistatin, Vitarna, cybernetic implants, etc.)Buying bioDAO products in online/offline stores

IP Tokens
Intellectual Property Tokens ("IP-Tokens" or "IPTs"), pioneered by Molecule AG, represent fractional governance rights over the intellectual property (IP) generated. These tokens give holders opportunity to participate directly in the development, decision-making, and future directions of the research.
BioDAOs & IPTs
BioDAOs develop and acquire ownership in IP-Tokens. Each BioDAO typically holds a portfolio of IP-Tokens representing intellectual property related to the BioDAO's specific area of scientific research. VitaDAO, for instance, developed and owns stakes in the IPTs VitaRNA and VITA-FAST.
Ecosystem
BIO is a network of bioDAOs that each specialize in developing research and products in a specific scientific field, such as longevity science (VitaDAO), brain health (CerebrumDAO) and synthetic biology (ValleyDAO).
The bioDAOs listed in the table below were either incubated by or closely affiliated with the bio.xyz ecosystem, and as such are expected to play an active role in the future development and governance of the BIO protocol.
BIO Token
BIO is the native governance token of the BIO protocol. BIO may be used by holders to:
Signal which bioDAOs to support (curation)Vote on future BIO issuance or distribution; andImplement accelerator programs for the development of the network
The BIO token provides holders with access to:
Governance rights in network bioDAOsEarly bioDAO funding roundsFinancial rewards for health data contributions & clinical trial participationNew health products funded by bioDAOs
The BIO token was issued by Bio.xyz Association, a not-for-profit organization that serves as legal steward of the BIO infrastructure and treasury.
BIO token contract: 0xcb1592591996765Ec0eFc1f92599A19767ee5ffAvBIO (vesting BIO) token contract: 0x0d2ADB4Af57cdac02d553e7601456739857D2eF4
Bionomics
Initial Distribution
Total Supply: 3,320,000,000
BIO Token Status: Non-transferrable
Max Supply: Uncapped supply, to be voted on by BIO governance.
New BIO can be minted for future protocol or network growth. This requires deploying a new token contract to replace the current BIO token.
BIO Allocation at Genesis
BIO's total supply at Genesis will be split across eight categories described in the chart and table below.

Community: 56%Community Auction: 20%Community Airdrop: 6%Ecosystem Incentives: 25%Molecule Ecosystem Fund: 5%Investors: 13.6%Core Contributors: 21.2%Advisors: 4.2%Molecule: 5%
Unlocked BIO Supply Schedules
Unlocked supply differs from circulating supply, this is the total supply that is unlocked and can be used, but not necessarily deployed.

Circulating Supply Distribution in the first 3 years
Given the 6 year vesting schedules of core team and investors, the following section gives a break down of the circulating supply distribution at the end of the first 3 years. This excludes any community directed inflation.

Inflation
BIO inflation plays a role in the secondary market liquidity function of the protocol, and therefore only inflates as the network of bioDAOs grow. Specific details on the inflation rate is TBD.
BIO Token Utility
BIO is a governance utility token for the governance of the BIO protocol.
BIO protocol governance may include decisions on:
Curation of BioDAOs joining the BIO NetworkTerms for participation in BioDAOs and their IP token salesSupport for and discounts on BioDAO health products/servicesMeta-governance within member BioDAOsBIO emissions, treasury allocations, and BIO protocol upgrades
BIO Value Accrual
The BIO treasury accrues value through a variety of mechanisms, including:
Token Allocations
BIO Network provides incubated BioDAOs with a $100,000 grant in exchange for 6.9% of the BioDAO’s token supply. These token allocation accrue in the BIO Treasury, growing protocol AUM as the network underlying DAOs rise in the value. The BIO treasury can also receive allocations of bioDAO scientific IP assets.
Protocol-Owned Liquidity (POL)
The BIO treasury accrues fees and yields from its onchain liquidity in BIO tokens, BioDAO tokens, IP tokens, ETH, and other assets, building POL.
BIO Genesis (Token Launch)
The design for BIO Genesis 2 was voted on by BIO governance in BIOPSY-10. BIO Genesis is designed to seed the network with liquidity and generate a diversified treasury for the protocol that can be used to support funding, liquidity, governance and incentives for BioDAOs in the network.
The details for BIO Genesis 1 can be found in BIOPSY-7.
BIO Airdrop
You can check eligibility and claim the BIO Airdrop here: https://claim.bio.xyz
Full details of the BIO Airdrop can be found in BIOPSY-3.
Details:
3% of BIO supply airdropped>8,500 addresses qualifiedThe snapshot for the aidrop was taken on April 1, 2024Users claim vBIO (vested BIO) that is immediately redeemable for $BIOThe $BIO token is non-transferrable until governance votes to unlock it.
Eligibility Criteria:
Placed bids in bioDAO* auctionsHeld >$100 of bioDAO tokens before April 1, 2024Provided liquidity for bioDAO tokensActively participated in bioDAO DiscordsCore contributor at a bioDAODonate to DeSci projects on Gitcoin (Round 15, 17 & Hyper DeSci were included with minimum of $50 total donations)

The airdrop is fully vested upon claiming. The BIO token is currently non-transferable. For technical reasons, we distribute all tokens through the vBIO contract. Airdrop recipients may convert their vBIO into BIO at any time, although there is no practical reason to do so until BIO becomes transferable, as determined by a governance vote.
bioGenesis Airdrop
There was also a small airdrop, amounting to 1% of the total supply, allocated to the initial BIO core community which consists of individuals who have contributed to building and participating in the program over its first 2 years. The terms for this airdrop include a 1-year cliff followed by a 6-year vesting period, managed through the vBIO contract.
BIO Launchpool Details:
Token Name: BIO Protocol (BIO)Max Token Supply: 3,320,000,000 BIO (dynamic, may increase via network governance) Total Genesis Token Supply: 3,320,000,000 BIO Launchpool Token Rewards: 99,600,000 BIO (3% of total genesis token supply)Initial Circulating Supply When Listed on Binance Spot: 1,296,529,168 BIO (39.05% of total genesis token supply)Research Report: BIO Protocol (BIO)
Hourly Hard Cap per User: 35,275 BIO in BNB pool6,225 BIO in FDUSD pool
Supported Pools: 
Lock BNB (webpage will be available in around 12 hours): 84,660,000 BIO in rewards (85%) Lock FDUSD (webpage will be available in around 12 hours): 14,940,000 BIO in rewards (15%)Farming Period: 2024-12-24 00:00 (UTC) to 2025-01-02 23:59 (UTC).

Instructions for Staking BNB and FDUSD to join Launchpool

Learn more: Binance Announcements

Advisors

Meet the BIO Team

Investor

Ecosystem

Project Links
WebsiteXWhitepaper

#Binance #BinanceLaunchpoolBIO #wendy $BNB $FDUSD